David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
CNA Financial
CNA
$13.3B
| $599K | ﹤0.01% |
+14,272
| New | +$623K |
|
3827
CALL
Invesco Mortgage Capital
IVR
$801M
| $599K | ﹤0.01% |
19,000
| – | – |
|
3828
Everspin Technologies
MRAM
$429M
| $599K | ﹤0.01% |
92,409
+64,735
| +234% | +$397K |
|
3829
StoneX
SNEX
$8.4B
| $598K | ﹤0.01% |
45,952
+71
| +0.2% | +$913 |
|
|
TRIL
3830
DELISTED
Trillium Therapeutics Inc.
TRIL
| $597K | ﹤0.01% |
34,014
-23,022
| -40% | -$269K |
|
3831
SunPower Inc
SPWR
$61.4M
| $595K | ﹤0.01% |
61,067
+44,870
| +277% | +$435K |
|
|
VMW
3832
PUT
DELISTED
VMware, Inc
VMW
| $595K | ﹤0.01% |
4,000
| – | – |
|
3833
Quantum Corp
QMCO
$882M
| $594K | ﹤0.01% |
5,731
+196
| +4% | +$23.1K |
|
3834
RE/MAX Holdings
RMAX
$263M
| $592K | ﹤0.01% |
18,984
+11,921
| +169% | +$396K |
|
3835
CALL
Colgate-Palmolive
CL
$72.8B
| $590K | ﹤0.01% |
+7,800
| New | +$619K |
|
|
STR
3836
DELISTED
Sitio Royalties
STR
| $590K | ﹤0.01% |
31,357
-19,132
| -38% | -$357K |
|
|
BRSP
3837
BrightSpire Capital
BRSP
$616M
| $589K | ﹤0.01% |
+62,757
| New | +$607K |
|
3838
PUT
Ross Stores
ROST
$77.4B
| $588K | ﹤0.01% |
+5,400
| New | +$647K |
|
|
SPTN
3839
DELISTED
SpartanNash
SPTN
| $588K | ﹤0.01% |
+26,868
| New | +$540K |
|
3840
Enanta Pharmaceuticals
ENTA
$410M
| $587K | ﹤0.01% |
10,336
-14,404
| -58% | -$712K |
|
|
FCRD
3841
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $586K | ﹤0.01% |
132,901
| – | – |
|
3842
Allogene Therapeutics
ALLO
$750M
| $584K | ﹤0.01% |
22,708
-179,555
| -89% | -$4.26M |
|
|
HUYA
3843
PUT
Huya Inc
HUYA
$491M
| $584K | ﹤0.01% |
70,000
| – | – |
|
3844
Universal Logistics Holdings
ULH
$509M
| $584K | ﹤0.01% |
29,068
+5,663
| +24% | +$122K |
|
3845
Vera Bradley
VRA
$91M
| $583K | ﹤0.01% |
61,917
-44,597
| -42% | -$489K |
|
|
3846
PUT
Colgate-Palmolive
CL
$72.8B
| $582K | ﹤0.01% |
+7,700
| New | +$611K |
|
3847
Zumiez
ZUMZ
$311M
| $582K | ﹤0.01% |
+14,645
| New | +$625K |
|
|
GATO
3848
DELISTED
Gatos Silver, Inc.
GATO
| $582K | ﹤0.01% |
+50,030
| New | +$697K |
|
3849
BlackRock Corporate High Yield Fund
HYT
$1.35B
| $580K | ﹤0.01% |
47,500
| – | – |
|
|
NUVA
3850
DELISTED
NuVasive, Inc.
NUVA
| $580K | ﹤0.01% |
+9,685
| New | +$597K |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.